Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Chronic Myeloid Leukemia Failed Second Generation Tyrosine Kinase Inhibitor Patients' Molecular Interrogation Using Next Generation Sequencing

SiewLian Chong, Yang Liang Boo, Wirda Asnawi, Pek Kuen Liew, Tee Chuan Ong, Veena Selvaratnam, Sharifah Shahnaz Syed Abd Kadir, Jerome Tan, KIM Wah HO, Yih Seong Seong Wong, Soo Min Lim, Subramanian Yegappan, Sen Mui Tan

Blood (2022) 140 (Supplement 1): 11544–11545.

https://doi.org/10.1182/blood-2022-162155

Published: 2022

Journal Articles

Risk Factors and Outcome of COVID-19 Infection in Haematological Patients : A Multicenter Retrospective Analysis in Malaysia

Sui Keat, Ai Sim Goh, Carol Chew Yuen Goh, Hong Siew Tan, Tee Chuan Ong, Sen Mui Tan, Pei Ling Low, Kuldeep Kaur, Ee Leng Gan, See Guan Toh, Tze Shin Leong, Lee Ping Chew, Hock Hin Chua, Lily LL Wong, Gilbert Wilfred, Shan Shan Tan, Christopher Liam, Yang Liang Boo

Blood (2022) 140 (Supplement 1): 13232–13233.

https://doi.org/10.1182/blood-2022-165307

Published: 2022

Journal Articles

A Real-World Study to End Tyrosine Kinase Inhibitor in Chronic Myeloid Leukaemia (EnTIC) in Malaysia: One Year Follow-up of Multicenter Study in Malaysia

Blood (2022) 140 (Supplement 1): 12213–12214.

https://doi.org/10.1182/blood-2022-169104

Published: 2022

Journal Articles

Real World Treatment Outcomes for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant in Different Income Countries within Asia Pacific Region

Chin Sum Cheong, Sen Mui Tan, Soo Chin Ng, Tee Chuan Ong, Sharifah Shahnaz Syed Abd Kadir, Kim Wah Ho, Alan Teh, Haris Abdul Rahman, Ping Chong Bee, Naomi Aoki, Pin-Yen Chen, Erica M. Wood, Andrew Spencer, Elizabeth M. Moore, Wee Joo Chng, Gin Gin Gan

Blood (2022) 140 (Supplement 1): 12541–12543.

https://doi.org/10.1182/blood-2022-164888

Published: 2022

Journal Articles

Treatment Outcome and a Practical 10-Point Prognostic Index in Adult Patients with Non-M3 Acute Myeloid Leukemia: A Retrospective, Multicenter Study in Malaysia

Tze Shin Leong, MBBS,MRCP,MSc, Sen Mui Tan, Lee Ping Chew, Tee Chuan Ong, Siew Lian Chong, Kar Ying Yong, Siong Leng Hon, Syazarin Fidhora Nasution, Ching Tiong Ko, Vanusha Devaraja, Andy Sing Ong Tang, Tsen Chuen Jerome Tan, Ngee Siang Lau, Sharifah Shahnaz Syed Abd Kadir, Veena Selvaratnam, Yee Yee Yap, Bee Sun Lee, William Kian Boon Law, Jameela Sathar

Blood (2019) 134 (Supplement_1): 2606.

https://doi.org/10.1182/blood-2019-126656

Published: 2019

Journal Articles

Final Analysis: Phase II Study of Oral Panobinostat In Relapsed/Refractory Hodgkin Lymphoma Patients Following Autologous Hematopoietic Stem Cell Transplant

Anna Sureda, MD, PhD, Anas Younes, MD, Dina Ben-Yehuda, Tee-Chuan Ong, Jonathan L. Kaufman, MD, Christophe Le Corre, Jennifer Gallagher, Angela Shen, MD, Andreas Engert, MD

Blood (2010) 116 (21): 419.

https://doi.org/10.1182/blood.V116.21.419.419

Published: 2010

Journal Articles

Efficacy of Panobinostat in Phase II Study in Patients with Relapsed/Refractory Hodgkin Lymphoma (HL) After High-Dose Chemotherapy with Autologous Stem Cell Transplant.

Anas Younes, MD, Tee-Chuan Ong, MD, Vincent Ribrag, MD, Andreas Engert, MD, Dina Ben-Yehuda, MD, Robin McCabe, Angela Shen, MD, Christophe Le Corre, Samit Hirawat, MD, Anna Sureda, MD, PhD

Blood (2009) 114 (22): 923.

https://doi.org/10.1182/blood.V114.22.923.923

Published: 2009

Journal Articles

Efficacy, Safety and Tolerability of Biotene Mouthwash Versus Aloe Vera Juice and Active Manuka Honey for Prophylaxis of Oral Mucositis Following Chemoradiotheray

Kian Meng Chang, MBBS, Tee Chuan Ong, Sen Mui Tan, Swee Kim Tan

Blood (2008) 112 (11): 4703.

https://doi.org/10.1182/blood.V112.11.4703.4703

Published: 2008

Journal Articles

Experience in Using Hypercvad Combined with Alemtuzumab in Treating Peripheral T-Cell and T/NK-Cell Neoplasms

Jew Win Kuan, MRCP, Ngee Siang Lau, MRCP, Kian Meng Chang, FRCPA, Sen Mui Tan, MRCP, Tee Chuan Ong, MRCP, Visalachy Purushothamaný, MRCPath

Blood (2008) 112 (11): 5013.

https://doi.org/10.1182/blood.V112.11.5013.5013

Published: 2008

NARROW

Chronic Myeloid Leukemia Failed Second Generation Tyrosine Kinase Inhibitor Patients' Molecular Interrogation Using Next Generation Sequencing

Risk Factors and Outcome of COVID-19 Infection in Haematological Patients : A Multicenter Retrospective Analysis in Malaysia

A Real-World Study to End Tyrosine Kinase Inhibitor in Chronic Myeloid Leukaemia (EnTIC) in Malaysia: One Year Follow-up of Multicenter Study in Malaysia

Real World Treatment Outcomes for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant in Different Income Countries within Asia Pacific Region

Treatment Outcome and a Practical 10-Point Prognostic Index in Adult Patients with Non-M3 Acute Myeloid Leukemia: A Retrospective, Multicenter Study in Malaysia

Final Analysis: Phase II Study of Oral Panobinostat In Relapsed/Refractory Hodgkin Lymphoma Patients Following Autologous Hematopoietic Stem Cell Transplant

Efficacy of Panobinostat in Phase II Study in Patients with Relapsed/Refractory Hodgkin Lymphoma (HL) After High-Dose Chemotherapy with Autologous Stem Cell Transplant.

Efficacy, Safety and Tolerability of Biotene Mouthwash Versus Aloe Vera Juice and Active Manuka Honey for Prophylaxis of Oral Mucositis Following Chemoradiotheray

Experience in Using Hypercvad Combined with Alemtuzumab in Treating Peripheral T-Cell and T/NK-Cell Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only